Hebei Changshan Biochemical Pharmaceutical Co Ltd
SZSE:300255
Hebei Changshan Biochemical Pharmaceutical Co Ltd
SZSE:300255
Price:
41.06
CNY
-0.87%
Market Closed
Market Cap:
¥37.7B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Hebei Changshan Biochemical Pharmaceutical Co Ltd
SZSE:300255
|
CN |
|
Karnalyte Resources Inc
TSX:KRN
|
CA |
|
Aemetis Inc
NASDAQ:AMTX
|
US |
|
Credito Real SAB de CV SOFOM ENR
BMV:CREAL
|
MX |
|
L
|
LHC Group Inc
F:LH6
|
US |
|
S
|
Susmed Inc
TSE:4263
|
JP |
|
Premier Ltd
NSE:PREMIER
|
IN |
|
P
|
Pan Entertainment Co Ltd
KOSDAQ:068050
|
KR |
|
Goodluck India Ltd
NSE:GOODLUCK
|
IN |
|
Il Sole 24 Ore SpA
F:4IL1
|
IT |
|
M
|
Metro Bank Holdings PLC
OTC:MTRBF
|
UK |
|
G
|
Geely Automobile Holdings Ltd
XHAM:GRU
|
HK |
|
S
|
Smartgroup Corporation Ltd
ASX:SIQ
|
AU |
|
S
|
SR Bancorp Inc
NASDAQ:SRBK
|
US |
|
DFI Inc
TWSE:2397
|
TW |
|
Fredun Pharmaceuticals Ltd
BSE:539730
|
IN |
|
Code Green Apparel Corp
OTC:CGAC
|
US |
|
Recursion Pharmaceuticals Inc
NASDAQ:RXRX
|
US |
|
Cascades Inc
TSX:CAS
|
CA |
|
Yealink Network Technology Co Ltd
SZSE:300628
|
CN |
|
Asia-Pacific Strategic Investments Ltd
SGX:5RA
|
SG |
Multiples-Based Value
The
Multiples-Based Value for
Hebei Changshan Biochemical Pharmaceutical Co Ltd (300255)
under the Base Case is
hidden
CNY.
Compared with the current market price of 41.06 CNY, the stock appears
hidden
.
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
Hebei Changshan Biochemical Pharmaceutical Co Ltd Multiples-Based Value
LOCKED
Multiples Across Competitors
Competitors Multiples
Hebei Changshan Biochemical Pharmaceutical Co Ltd Competitors
Hebei Changshan Biochemical Pharmaceutical Co Ltd Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| CN |
|
Hebei Changshan Biochemical Pharmaceutical Co Ltd
SZSE:300255
|
37.7B CNY | 40.7 | -125.1 | -212.1 | -212.1 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
887.6B USD | 13.5 | 42.6 | 28.7 | 30.6 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
574.2B USD | 6.1 | 21.4 | 14.9 | 18.3 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
248.4B CHF | 4.1 | 19.5 | 11.6 | 13 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
232.5B GBP | 5.2 | 30.1 | 16.6 | 23.5 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
300.5B USD | 4.6 | 16.3 | 10.1 | 12.3 | |
| CH |
|
Novartis AG
SIX:NOVN
|
233.6B CHF | 5.2 | 20.8 | 12.9 | 16.5 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
244.4B USD | 105.4 | -83.6 | 386.8 | 970 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.1T DKK | 3.4 | 10.4 | 7.7 | 9 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
153.1B USD | 2.5 | 20 | 7.7 | 10.2 | |
| UK |
|
GlaxoSmithKline PLC
LSE:GSK
|
88.4B GBP | 2.7 | 15.5 | 8.4 | 10.4 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
